Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06674980 · ClinicalTrials.gov registry record · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
A NA study of Cardiovascular Diseases and Diabetes Mellitus, sponsored by C5 Biomedical.
- Recruiting
- Registry status
- NA
- Development phase
- 177
- Enrollment target
- 1
- Study location
NCT06674980 is a NA study of Cardiovascular Diseases and Diabetes Mellitus that is actively recruiting participants, run by C5 Biomedical. The registered enrollment target is 177 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06674980, a NA study of Cardiovascular Diseases and Diabetes Mellitus, is actively recruiting participants, sponsored by C5 Biomedical.
- RECRUITING
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
Conditions Studied
Interventions
- OTHER Standard of Care - DFU
- OTHER AM/Single - DFU
- OTHER AM/Double - DFU
- OTHER Standard of Care - VLU
- OTHER AM/Single - VLU
Study Locations (1)
Louisiana
- Poirot Podiatry - Metairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2024-12-20 |
| Est. Completion | 2027-01-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06674980
The ClinicalTrials.gov registry entry for NCT06674980 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is C5 Biomedical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 5 interventions - of which Standard of Care - DFU is the first listed.
NCT06674980 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06674980 about?
NCT06674980 is a clinical study titled "Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs". The purpose of the study is to evaluate the efficacy of multiple human placental membrane products and Standard of Care (SOC) versus SOC alone in the management of nonhealing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) over 12 weeks using a modified platform trial design.
What is the current status of trial NCT06674980?
This trial is currently recruiting. It is a NA study. The enrollment target is 177 participants. The study started on 2024-12-20. Estimated completion is 2027-01-22.
What conditions does trial NCT06674980 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Diabetes Mellitus, Vascular Diseases, Glucose Metabolism Disorders, Pathologic Processes.
What interventions are being tested in trial NCT06674980?
The interventions under investigation include: Standard of Care - DFU (OTHER), AM/Single - DFU (OTHER), AM/Double - DFU (OTHER), Standard of Care - VLU (OTHER), AM/Single - VLU (OTHER).
Who is sponsoring clinical trial NCT06674980?
This trial is sponsored by C5 Biomedical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06674980 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.